Study of XL820 Given Orally Daily to Subjects With Solid Tumors - Related Studies

Home

Study of XL820 Given Orally Daily to Subjects With Solid Tumors

This study has been completed.

Study NCT00350831. Last updated on August 14, 2008. Information provided by Exelixis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cancer

2	Interventions listed in this trial
		XL820

3	Sponsors listed in this trial
		Exelixis